Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Affymax Will Rise Again
Seeking Alpha
Wednesday, March 20, 2013 - 1:10pm
tags:
Affymax, Takeda
BioLineRx Shares Fall On Schizophrenia Drug Failure
TheStreet.com
Wednesday, March 20, 2013 - 12:58pm
tags:
schizophrenia, BioLineRx, BL-1020
Arena Joins Vivus Finding Obesity Drugs Fizzle on Costs
Bloomberg
Wednesday, March 20, 2013 - 12:27pm
tags:
Vivus, Arena Pharmaceuticals, obesity, Qsymia, Belviq
BioMarin says it will continue studies of late-onset Pompe disease drug candidate BMN-701
Yahoo/AP
Wednesday, March 20, 2013 - 12:26pm
tags:
Biomarin, Pompe disease, BMN-701
Valeant Buying Obagi Medical; Both Stocks Jump
Investors.com
Wednesday, March 20, 2013 - 12:23pm
tags:
Valeant Pharmaceuticals, Obagi Medical Products, M&A
Supreme Court to Consider Frozen Funds of Former J&J Sales Representative
NASDAQ.com
Wednesday, March 20, 2013 - 12:14pm
tags:
Supreme Court, JNJ, drug reps
Biogen’s MS Pill Gains 8 More Years of Patent Protection
Bloomberg
Wednesday, March 20, 2013 - 12:12pm
tags:
MS, multiple sclerosis, patents, Biogen Idec, Tecfidera
Apotex Is In The FDA Dog House, Again
Pharmalot
Wednesday, March 20, 2013 - 12:11pm
tags:
FDA, generics, Apotex
Cerecor gets rights to potential drugs for Parkinson's disease and other illnesses from Merck
Yahoo/AP
Wednesday, March 20, 2013 - 12:10pm
tags:
Merck, Cerecor, Parkinson's Disease, COMT inhibitors
Genmab Rises as Nordea Says Bet on Cancer Drug: Copenhagen Mover
Bloomberg
Wednesday, March 20, 2013 - 12:09pm
tags:
Genmab, JNJ, daratumumab, Multiple Myeloma
Enanta: Pharmaceutical Company Treats Shareholders With An IPO
Seeking Alpha
Wednesday, March 20, 2013 - 12:07pm
tags:
Ananta, IPOs, Novartis, AbbVie, Tetraphase Pharmaceuticals
Alimera Sciences: About To Cash In?
Motley Fool
Wednesday, March 20, 2013 - 12:06pm
tags:
Alimera
Novartis Scores European Approval for Jetrea
Motley Fool
Wednesday, March 20, 2013 - 12:06pm
tags:
Novartis, Jetrea, Alcon
Tackling Cancer: Lung Cancer's Biggest Current and Upcoming Players
Motley Fool
Wednesday, March 20, 2013 - 11:56am
tags:
lung cancer, Roche, Avastin, Tarceva, Astellas, Pfizer, Xalkori, Celgene, Abraxane, Gemzar, Alimta, Eli Lilly
Modified Cold Sore Virus Shrinks Melanoma Tumors, Amgen Says
Forbes
Wednesday, March 20, 2013 - 11:54am
tags:
melanoma, Amgen, GM-CSF
Novo Nordisk’s Oral Insulin Successfully Completes Early Study
Bloomberg
Wednesday, March 20, 2013 - 11:54am
tags:
insulin, Novo Nordisk, diabetes, Merrion
Titan’s Probuphine Dosing May Need Review, FDA Staff Says
Bloomberg
Tuesday, March 19, 2013 - 11:17am
tags:
Titan Pharmaceuticals, FDA, Probuphine, addiction
Zalicus presents data on state-dependent ion channel screening
Yahoo/Fly on the Wall
Tuesday, March 19, 2013 - 11:16am
tags:
Zalicus, ion channel screening, calcium channel blockers
DB Analyst Gets It: Sarepta Is a Winner Even Without Accelerated Approval
TheStreet.com
Tuesday, March 19, 2013 - 11:14am
tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
Strong Relistor Sales Drive New Rally In Progenics
Seeking Alpha
Tuesday, March 19, 2013 - 11:13am
tags:
Progenics, Relistor, Salix, opioid-induced bowel dysfunction

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.